A subset of HLA-DP molecules serve as ligands for the natural cytotoxicity receptor NKp44
Natural killer (NK) cells can recognize virus-infected and stressed cells 1 using activating and inhibitory receptors, many of which interact with HLA class I. Although early studies also suggested a functional impact of HLA class II on NK cell activity 2 , 3 , the NK cell receptors that specificall...
Gespeichert in:
Veröffentlicht in: | Nature immunology 2019-09, Vol.20 (9), p.1129-1137 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1137 |
---|---|
container_issue | 9 |
container_start_page | 1129 |
container_title | Nature immunology |
container_volume | 20 |
creator | Niehrs, Annika Garcia-Beltran, Wilfredo F. Norman, Paul J. Watson, Gabrielle M. Hölzemer, Angelique Chapel, Anaïs Richert, Laura Pommerening-Röser, Andreas Körner, Christian Ozawa, Mikki Martrus, Glòria Rossjohn, Jamie Lee, Jar-How Berry, Richard Carrington, Mary Altfeld, Marcus |
description | Natural killer (NK) cells can recognize virus-infected and stressed cells
1
using activating and inhibitory receptors, many of which interact with HLA class I. Although early studies also suggested a functional impact of HLA class II on NK cell activity
2
,
3
, the NK cell receptors that specifically recognize HLA class II molecules have never been identified. We investigated whether two major families of NK cell receptors, killer-cell immunoglobulin-like receptors (KIRs) and natural cytotoxicity receptors (NCRs), contained receptors that bound to HLA class II, and identified a direct interaction between the NK cell receptor NKp44 and a subset of HLA-DP molecules, including HLA-DP401, one of the most frequent class II allotypes in white populations
4
. Using NKp44ζ
+
reporter cells and primary human NKp44
+
NK cells, we demonstrated that interactions between NKp44 and HLA-DP401 trigger functional NK cell responses. This interaction between a subset of HLA-DP molecules and NKp44 implicates HLA class II as a component of the innate immune response, much like HLA class I. It also provides a potential mechanism for the described associations between HLA-DP subtypes and several disease outcomes, including hepatitis B virus infection
5
–
7
, graft-versus-host disease
8
and inflammatory bowel disease
9
,
10
.
NK cells recognize class I and stress-associated ligands. Altfeld and colleagues identify the NK cell receptor NKp44 as directly interacting with the class II HLA-DP in a partially peptide-dependent manner and with functional consequences for NK cell activity. |
doi_str_mv | 10.1038/s41590-019-0448-4 |
format | Article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8370669</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A597210661</galeid><sourcerecordid>A597210661</sourcerecordid><originalsourceid>FETCH-LOGICAL-c560t-273e4b31f229abe05d50f86853f9547886f233f312dad76b5cf2fc9db3a0fd1f3</originalsourceid><addsrcrecordid>eNp9kstu1DAUhiMEoqXwAGyQJTawCBxfY2-QonIZxAhYwIKV5Tj2TKpMPLWTEfP2OEqZQiVY-cjnO_-56C-KpxheYaDydWKYKygBqxIYkyW7V5xjTlRJFBb3TzHIs-JRSlcAmFWCPSzOKKZcKiXPix81SlOT3IiCR6t1Xb79inahd3bqXULJxYNDJqG-25ihTciHiMatQ4MZp2h6ZI9jGMPPznbjEUVn3X7MxOdPe8YeFw-86ZN7cvNeFN_fv_t2uSrXXz58vKzXpeUCxpJU1LGGYk-IMo0D3nLwUkhOveKsklJ4QqmnmLSmrUTDrSfeqrahBnyLPb0o3iy6-6nZuda6YcyT6X3sdiYedTCd_jszdFu9CQctaQVCqCzwchHY3ilb1Ws9_wFhRCjAB5zZFzfNYrieXBr1rkvW9b0ZXJiSJkRUQKRUkNHnd9CrMMUhn0ITVnEQALL6L0UqCUA5ZrfUxvROd4MPeRM7t9Y1VxXBeZF5OLxQNoaUovOnbTDo2TB6MYzOhtGzYfSs_OzP650qfjskA2QBUk4NGxdvB_y36i-Lbsgl</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2278003514</pqid></control><display><type>article</type><title>A subset of HLA-DP molecules serve as ligands for the natural cytotoxicity receptor NKp44</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><source>Nature</source><creator>Niehrs, Annika ; Garcia-Beltran, Wilfredo F. ; Norman, Paul J. ; Watson, Gabrielle M. ; Hölzemer, Angelique ; Chapel, Anaïs ; Richert, Laura ; Pommerening-Röser, Andreas ; Körner, Christian ; Ozawa, Mikki ; Martrus, Glòria ; Rossjohn, Jamie ; Lee, Jar-How ; Berry, Richard ; Carrington, Mary ; Altfeld, Marcus</creator><creatorcontrib>Niehrs, Annika ; Garcia-Beltran, Wilfredo F. ; Norman, Paul J. ; Watson, Gabrielle M. ; Hölzemer, Angelique ; Chapel, Anaïs ; Richert, Laura ; Pommerening-Röser, Andreas ; Körner, Christian ; Ozawa, Mikki ; Martrus, Glòria ; Rossjohn, Jamie ; Lee, Jar-How ; Berry, Richard ; Carrington, Mary ; Altfeld, Marcus</creatorcontrib><description>Natural killer (NK) cells can recognize virus-infected and stressed cells
1
using activating and inhibitory receptors, many of which interact with HLA class I. Although early studies also suggested a functional impact of HLA class II on NK cell activity
2
,
3
, the NK cell receptors that specifically recognize HLA class II molecules have never been identified. We investigated whether two major families of NK cell receptors, killer-cell immunoglobulin-like receptors (KIRs) and natural cytotoxicity receptors (NCRs), contained receptors that bound to HLA class II, and identified a direct interaction between the NK cell receptor NKp44 and a subset of HLA-DP molecules, including HLA-DP401, one of the most frequent class II allotypes in white populations
4
. Using NKp44ζ
+
reporter cells and primary human NKp44
+
NK cells, we demonstrated that interactions between NKp44 and HLA-DP401 trigger functional NK cell responses. This interaction between a subset of HLA-DP molecules and NKp44 implicates HLA class II as a component of the innate immune response, much like HLA class I. It also provides a potential mechanism for the described associations between HLA-DP subtypes and several disease outcomes, including hepatitis B virus infection
5
–
7
, graft-versus-host disease
8
and inflammatory bowel disease
9
,
10
.
NK cells recognize class I and stress-associated ligands. Altfeld and colleagues identify the NK cell receptor NKp44 as directly interacting with the class II HLA-DP in a partially peptide-dependent manner and with functional consequences for NK cell activity.</description><identifier>ISSN: 1529-2908</identifier><identifier>ISSN: 1529-2916</identifier><identifier>EISSN: 1529-2916</identifier><identifier>DOI: 10.1038/s41590-019-0448-4</identifier><identifier>PMID: 31358998</identifier><language>eng</language><publisher>New York: Nature Publishing Group US</publisher><subject>631/250/1619/382 ; 631/250/2504 ; Allotypes ; Biomedical and Life Sciences ; Biomedicine ; Cell Line ; Cytotoxicity ; Graft vs Host Disease - immunology ; Health aspects ; Hepatitis B ; Hepatitis B - immunology ; Histocompatibility antigen HLA ; HLA-DP Antigens - immunology ; Humans ; Immune response ; Immunity, Innate - immunology ; Immunoglobulin-like receptors ; Immunology ; Infectious Diseases ; Inflammatory bowel diseases ; Inflammatory Bowel Diseases - immunology ; Innate immunity ; Intestine ; Jurkat Cells ; Killer cells ; Killer Cells, Natural - immunology ; Letter ; Life Sciences ; Ligands ; Ligands (Biochemistry) ; Natural Cytotoxicity Triggering Receptor 2 - immunology ; Natural killer cells</subject><ispartof>Nature immunology, 2019-09, Vol.20 (9), p.1129-1137</ispartof><rights>The Author(s), under exclusive licence to Springer Nature America, Inc. 2019</rights><rights>COPYRIGHT 2019 Nature Publishing Group</rights><rights>Copyright Nature Publishing Group Sep 2019</rights><rights>The Author(s), under exclusive licence to Springer Nature America, Inc. 2019.</rights><rights>Attribution</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c560t-273e4b31f229abe05d50f86853f9547886f233f312dad76b5cf2fc9db3a0fd1f3</citedby><cites>FETCH-LOGICAL-c560t-273e4b31f229abe05d50f86853f9547886f233f312dad76b5cf2fc9db3a0fd1f3</cites><orcidid>0000-0001-8370-7703 ; 0000-0002-2190-4346 ; 0000-0002-2692-2180 ; 0000-0002-2020-7522 ; 0000-0001-7043-0469 ; 0000-0001-5972-2997 ; 0000-0003-0056-7528</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/s41590-019-0448-4$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/s41590-019-0448-4$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,776,780,881,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31358998$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://inria.hal.science/hal-02426901$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Niehrs, Annika</creatorcontrib><creatorcontrib>Garcia-Beltran, Wilfredo F.</creatorcontrib><creatorcontrib>Norman, Paul J.</creatorcontrib><creatorcontrib>Watson, Gabrielle M.</creatorcontrib><creatorcontrib>Hölzemer, Angelique</creatorcontrib><creatorcontrib>Chapel, Anaïs</creatorcontrib><creatorcontrib>Richert, Laura</creatorcontrib><creatorcontrib>Pommerening-Röser, Andreas</creatorcontrib><creatorcontrib>Körner, Christian</creatorcontrib><creatorcontrib>Ozawa, Mikki</creatorcontrib><creatorcontrib>Martrus, Glòria</creatorcontrib><creatorcontrib>Rossjohn, Jamie</creatorcontrib><creatorcontrib>Lee, Jar-How</creatorcontrib><creatorcontrib>Berry, Richard</creatorcontrib><creatorcontrib>Carrington, Mary</creatorcontrib><creatorcontrib>Altfeld, Marcus</creatorcontrib><title>A subset of HLA-DP molecules serve as ligands for the natural cytotoxicity receptor NKp44</title><title>Nature immunology</title><addtitle>Nat Immunol</addtitle><addtitle>Nat Immunol</addtitle><description>Natural killer (NK) cells can recognize virus-infected and stressed cells
1
using activating and inhibitory receptors, many of which interact with HLA class I. Although early studies also suggested a functional impact of HLA class II on NK cell activity
2
,
3
, the NK cell receptors that specifically recognize HLA class II molecules have never been identified. We investigated whether two major families of NK cell receptors, killer-cell immunoglobulin-like receptors (KIRs) and natural cytotoxicity receptors (NCRs), contained receptors that bound to HLA class II, and identified a direct interaction between the NK cell receptor NKp44 and a subset of HLA-DP molecules, including HLA-DP401, one of the most frequent class II allotypes in white populations
4
. Using NKp44ζ
+
reporter cells and primary human NKp44
+
NK cells, we demonstrated that interactions between NKp44 and HLA-DP401 trigger functional NK cell responses. This interaction between a subset of HLA-DP molecules and NKp44 implicates HLA class II as a component of the innate immune response, much like HLA class I. It also provides a potential mechanism for the described associations between HLA-DP subtypes and several disease outcomes, including hepatitis B virus infection
5
–
7
, graft-versus-host disease
8
and inflammatory bowel disease
9
,
10
.
NK cells recognize class I and stress-associated ligands. Altfeld and colleagues identify the NK cell receptor NKp44 as directly interacting with the class II HLA-DP in a partially peptide-dependent manner and with functional consequences for NK cell activity.</description><subject>631/250/1619/382</subject><subject>631/250/2504</subject><subject>Allotypes</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cell Line</subject><subject>Cytotoxicity</subject><subject>Graft vs Host Disease - immunology</subject><subject>Health aspects</subject><subject>Hepatitis B</subject><subject>Hepatitis B - immunology</subject><subject>Histocompatibility antigen HLA</subject><subject>HLA-DP Antigens - immunology</subject><subject>Humans</subject><subject>Immune response</subject><subject>Immunity, Innate - immunology</subject><subject>Immunoglobulin-like receptors</subject><subject>Immunology</subject><subject>Infectious Diseases</subject><subject>Inflammatory bowel diseases</subject><subject>Inflammatory Bowel Diseases - immunology</subject><subject>Innate immunity</subject><subject>Intestine</subject><subject>Jurkat Cells</subject><subject>Killer cells</subject><subject>Killer Cells, Natural - immunology</subject><subject>Letter</subject><subject>Life Sciences</subject><subject>Ligands</subject><subject>Ligands (Biochemistry)</subject><subject>Natural Cytotoxicity Triggering Receptor 2 - immunology</subject><subject>Natural killer cells</subject><issn>1529-2908</issn><issn>1529-2916</issn><issn>1529-2916</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp9kstu1DAUhiMEoqXwAGyQJTawCBxfY2-QonIZxAhYwIKV5Tj2TKpMPLWTEfP2OEqZQiVY-cjnO_-56C-KpxheYaDydWKYKygBqxIYkyW7V5xjTlRJFBb3TzHIs-JRSlcAmFWCPSzOKKZcKiXPix81SlOT3IiCR6t1Xb79inahd3bqXULJxYNDJqG-25ihTciHiMatQ4MZp2h6ZI9jGMPPznbjEUVn3X7MxOdPe8YeFw-86ZN7cvNeFN_fv_t2uSrXXz58vKzXpeUCxpJU1LGGYk-IMo0D3nLwUkhOveKsklJ4QqmnmLSmrUTDrSfeqrahBnyLPb0o3iy6-6nZuda6YcyT6X3sdiYedTCd_jszdFu9CQctaQVCqCzwchHY3ilb1Ws9_wFhRCjAB5zZFzfNYrieXBr1rkvW9b0ZXJiSJkRUQKRUkNHnd9CrMMUhn0ITVnEQALL6L0UqCUA5ZrfUxvROd4MPeRM7t9Y1VxXBeZF5OLxQNoaUovOnbTDo2TB6MYzOhtGzYfSs_OzP650qfjskA2QBUk4NGxdvB_y36i-Lbsgl</recordid><startdate>20190901</startdate><enddate>20190901</enddate><creator>Niehrs, Annika</creator><creator>Garcia-Beltran, Wilfredo F.</creator><creator>Norman, Paul J.</creator><creator>Watson, Gabrielle M.</creator><creator>Hölzemer, Angelique</creator><creator>Chapel, Anaïs</creator><creator>Richert, Laura</creator><creator>Pommerening-Röser, Andreas</creator><creator>Körner, Christian</creator><creator>Ozawa, Mikki</creator><creator>Martrus, Glòria</creator><creator>Rossjohn, Jamie</creator><creator>Lee, Jar-How</creator><creator>Berry, Richard</creator><creator>Carrington, Mary</creator><creator>Altfeld, Marcus</creator><general>Nature Publishing Group US</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7QR</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>P64</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQGLB</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>RC3</scope><scope>7X8</scope><scope>1XC</scope><scope>VOOES</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-8370-7703</orcidid><orcidid>https://orcid.org/0000-0002-2190-4346</orcidid><orcidid>https://orcid.org/0000-0002-2692-2180</orcidid><orcidid>https://orcid.org/0000-0002-2020-7522</orcidid><orcidid>https://orcid.org/0000-0001-7043-0469</orcidid><orcidid>https://orcid.org/0000-0001-5972-2997</orcidid><orcidid>https://orcid.org/0000-0003-0056-7528</orcidid></search><sort><creationdate>20190901</creationdate><title>A subset of HLA-DP molecules serve as ligands for the natural cytotoxicity receptor NKp44</title><author>Niehrs, Annika ; Garcia-Beltran, Wilfredo F. ; Norman, Paul J. ; Watson, Gabrielle M. ; Hölzemer, Angelique ; Chapel, Anaïs ; Richert, Laura ; Pommerening-Röser, Andreas ; Körner, Christian ; Ozawa, Mikki ; Martrus, Glòria ; Rossjohn, Jamie ; Lee, Jar-How ; Berry, Richard ; Carrington, Mary ; Altfeld, Marcus</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c560t-273e4b31f229abe05d50f86853f9547886f233f312dad76b5cf2fc9db3a0fd1f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>631/250/1619/382</topic><topic>631/250/2504</topic><topic>Allotypes</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cell Line</topic><topic>Cytotoxicity</topic><topic>Graft vs Host Disease - immunology</topic><topic>Health aspects</topic><topic>Hepatitis B</topic><topic>Hepatitis B - immunology</topic><topic>Histocompatibility antigen HLA</topic><topic>HLA-DP Antigens - immunology</topic><topic>Humans</topic><topic>Immune response</topic><topic>Immunity, Innate - immunology</topic><topic>Immunoglobulin-like receptors</topic><topic>Immunology</topic><topic>Infectious Diseases</topic><topic>Inflammatory bowel diseases</topic><topic>Inflammatory Bowel Diseases - immunology</topic><topic>Innate immunity</topic><topic>Intestine</topic><topic>Jurkat Cells</topic><topic>Killer cells</topic><topic>Killer Cells, Natural - immunology</topic><topic>Letter</topic><topic>Life Sciences</topic><topic>Ligands</topic><topic>Ligands (Biochemistry)</topic><topic>Natural Cytotoxicity Triggering Receptor 2 - immunology</topic><topic>Natural killer cells</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Niehrs, Annika</creatorcontrib><creatorcontrib>Garcia-Beltran, Wilfredo F.</creatorcontrib><creatorcontrib>Norman, Paul J.</creatorcontrib><creatorcontrib>Watson, Gabrielle M.</creatorcontrib><creatorcontrib>Hölzemer, Angelique</creatorcontrib><creatorcontrib>Chapel, Anaïs</creatorcontrib><creatorcontrib>Richert, Laura</creatorcontrib><creatorcontrib>Pommerening-Röser, Andreas</creatorcontrib><creatorcontrib>Körner, Christian</creatorcontrib><creatorcontrib>Ozawa, Mikki</creatorcontrib><creatorcontrib>Martrus, Glòria</creatorcontrib><creatorcontrib>Rossjohn, Jamie</creatorcontrib><creatorcontrib>Lee, Jar-How</creatorcontrib><creatorcontrib>Berry, Richard</creatorcontrib><creatorcontrib>Carrington, Mary</creatorcontrib><creatorcontrib>Altfeld, Marcus</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>ProQuest Health & Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health & Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Applied & Life Sciences</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Nature immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Niehrs, Annika</au><au>Garcia-Beltran, Wilfredo F.</au><au>Norman, Paul J.</au><au>Watson, Gabrielle M.</au><au>Hölzemer, Angelique</au><au>Chapel, Anaïs</au><au>Richert, Laura</au><au>Pommerening-Röser, Andreas</au><au>Körner, Christian</au><au>Ozawa, Mikki</au><au>Martrus, Glòria</au><au>Rossjohn, Jamie</au><au>Lee, Jar-How</au><au>Berry, Richard</au><au>Carrington, Mary</au><au>Altfeld, Marcus</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A subset of HLA-DP molecules serve as ligands for the natural cytotoxicity receptor NKp44</atitle><jtitle>Nature immunology</jtitle><stitle>Nat Immunol</stitle><addtitle>Nat Immunol</addtitle><date>2019-09-01</date><risdate>2019</risdate><volume>20</volume><issue>9</issue><spage>1129</spage><epage>1137</epage><pages>1129-1137</pages><issn>1529-2908</issn><issn>1529-2916</issn><eissn>1529-2916</eissn><abstract>Natural killer (NK) cells can recognize virus-infected and stressed cells
1
using activating and inhibitory receptors, many of which interact with HLA class I. Although early studies also suggested a functional impact of HLA class II on NK cell activity
2
,
3
, the NK cell receptors that specifically recognize HLA class II molecules have never been identified. We investigated whether two major families of NK cell receptors, killer-cell immunoglobulin-like receptors (KIRs) and natural cytotoxicity receptors (NCRs), contained receptors that bound to HLA class II, and identified a direct interaction between the NK cell receptor NKp44 and a subset of HLA-DP molecules, including HLA-DP401, one of the most frequent class II allotypes in white populations
4
. Using NKp44ζ
+
reporter cells and primary human NKp44
+
NK cells, we demonstrated that interactions between NKp44 and HLA-DP401 trigger functional NK cell responses. This interaction between a subset of HLA-DP molecules and NKp44 implicates HLA class II as a component of the innate immune response, much like HLA class I. It also provides a potential mechanism for the described associations between HLA-DP subtypes and several disease outcomes, including hepatitis B virus infection
5
–
7
, graft-versus-host disease
8
and inflammatory bowel disease
9
,
10
.
NK cells recognize class I and stress-associated ligands. Altfeld and colleagues identify the NK cell receptor NKp44 as directly interacting with the class II HLA-DP in a partially peptide-dependent manner and with functional consequences for NK cell activity.</abstract><cop>New York</cop><pub>Nature Publishing Group US</pub><pmid>31358998</pmid><doi>10.1038/s41590-019-0448-4</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0001-8370-7703</orcidid><orcidid>https://orcid.org/0000-0002-2190-4346</orcidid><orcidid>https://orcid.org/0000-0002-2692-2180</orcidid><orcidid>https://orcid.org/0000-0002-2020-7522</orcidid><orcidid>https://orcid.org/0000-0001-7043-0469</orcidid><orcidid>https://orcid.org/0000-0001-5972-2997</orcidid><orcidid>https://orcid.org/0000-0003-0056-7528</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1529-2908 |
ispartof | Nature immunology, 2019-09, Vol.20 (9), p.1129-1137 |
issn | 1529-2908 1529-2916 1529-2916 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8370669 |
source | MEDLINE; Springer Nature - Complete Springer Journals; Nature |
subjects | 631/250/1619/382 631/250/2504 Allotypes Biomedical and Life Sciences Biomedicine Cell Line Cytotoxicity Graft vs Host Disease - immunology Health aspects Hepatitis B Hepatitis B - immunology Histocompatibility antigen HLA HLA-DP Antigens - immunology Humans Immune response Immunity, Innate - immunology Immunoglobulin-like receptors Immunology Infectious Diseases Inflammatory bowel diseases Inflammatory Bowel Diseases - immunology Innate immunity Intestine Jurkat Cells Killer cells Killer Cells, Natural - immunology Letter Life Sciences Ligands Ligands (Biochemistry) Natural Cytotoxicity Triggering Receptor 2 - immunology Natural killer cells |
title | A subset of HLA-DP molecules serve as ligands for the natural cytotoxicity receptor NKp44 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T17%3A59%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20subset%20of%20HLA-DP%20molecules%20serve%20as%20ligands%20for%20the%20natural%20cytotoxicity%20receptor%20NKp44&rft.jtitle=Nature%20immunology&rft.au=Niehrs,%20Annika&rft.date=2019-09-01&rft.volume=20&rft.issue=9&rft.spage=1129&rft.epage=1137&rft.pages=1129-1137&rft.issn=1529-2908&rft.eissn=1529-2916&rft_id=info:doi/10.1038/s41590-019-0448-4&rft_dat=%3Cgale_pubme%3EA597210661%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2278003514&rft_id=info:pmid/31358998&rft_galeid=A597210661&rfr_iscdi=true |